Stay updated on Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the study record. This update represents administrative version control rather than changes to the study content or eligibility criteria.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedClinicalTrials.gov record metadata was updated, including the posted/updated dates and the revision version. The listed study locations count increased from 173 to 174, reflecting a net addition of one study site.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision updated to v3.5.2; prior Revision v3.5.0 was removed.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page shows new update dates in April 2026 (April 6–7) and removes March 2026 entries, reflecting administrative record-keeping updates.SummaryDifference0.1%

- Check56 days agoChange DetectedAn Actual entry for 2026-04-01 was added to the update history and an Estimated entry for 2026-03-16 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded 'Squamous cell carcinoma of the head and neck' to the study's conditions/keywords and included 'Genetic and Rare Diseases Information Center' as a resources entry.SummaryDifference0.1%

Stay in the know with updates to Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.